BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24307515)

  • 21. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group.
    Bisio V; Zampini M; Tregnago C; Manara E; Salsi V; Di Meglio A; Masetti R; Togni M; Di Giacomo D; Minuzzo S; Leszl A; Zappavigna V; Rondelli R; Mecucci C; Pession A; Locatelli F; Basso G; Pigazzi M
    Leukemia; 2017 Apr; 31(4):974-977. PubMed ID: 27890935
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).
    Zhao W; Claxton DF; Medeiros LJ; Lu D; Vadhan-Raj S; Kantarjian HM; Nguyen MH; Bueso-Ramos CE
    Am J Surg Pathol; 2006 Nov; 30(11):1436-44. PubMed ID: 17063086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inv(11)(p15q22)/NUP98-DDX10 fusion and isoforms in a new case of de novo acute myeloid leukemia.
    Gorello P; Nofrini V; Brandimarte L; Pierini V; Crescenzi B; Nozza F; Daniele G; Storlazzi CT; Di Giacomo D; Matteucci C; La Starza R; Mecucci C
    Cancer Genet; 2013 Mar; 206(3):92-6. PubMed ID: 23522748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.
    Laczika K; Novak M; Hilgarth B; Mitterbauer M; Mitterbauer G; Scheidel-Petrovic A; Scholten C; Thalhammer-Scherrer R; Brugger S; Keil F; Schwarzinger I; Haas OA; Lechner K; Jaeger U
    J Clin Oncol; 1998 Apr; 16(4):1519-25. PubMed ID: 9552061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion.
    Meech SJ; McGavran L; Odom LF; Liang X; Meltesen L; Gump J; Wei Q; Carlsen S; Hunger SP
    Blood; 2001 Aug; 98(4):1209-16. PubMed ID: 11493472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
    Wang HY; Rashidi HH
    Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute minimally differentiated myeloid leukemia (M0) with inv(3)(q21q26).
    Fujisawa S; Tanabe J; Harano H; Kanamori H; Motomura S; Mohri H; Ishigatsubo Y
    Leuk Lymphoma; 1999 Nov; 35(5-6):627-30. PubMed ID: 10609803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A unique structural abnormality of chromosome 16 resulting in a CBF beta-MYH11 fusion transcript in a patient with acute myeloid leukemia, FAB M4.
    O'Reilly J; Chipper L; Springall F; Herrmann R
    Cancer Genet Cytogenet; 2000 Aug; 121(1):52-5. PubMed ID: 10958941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.
    Takeuchi K; Soda M; Togashi Y; Ota Y; Sekiguchi Y; Hatano S; Asaka R; Noguchi M; Mano H
    Haematologica; 2011 Mar; 96(3):464-7. PubMed ID: 21134980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelioid inflammatory myofibroblastic sarcoma arising in the pleural cavity.
    Kozu Y; Isaka M; Ohde Y; Takeuchi K; Nakajima T
    Gen Thorac Cardiovasc Surg; 2014 Mar; 62(3):191-4. PubMed ID: 23345154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myeloid leukemia with inv(16)(p13.1q22), abnormal eosinophils, and absence of peripheral blood and bone marrow blasts.
    Mangaru Z; Shetty S; Visconte V; Liu HD; Rogers HJ
    Am J Hematol; 2016 Jun; 91(4):E273-4. PubMed ID: 26719044
    [No Abstract]   [Full Text] [Related]  

  • 33. Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML).
    Kenealy M; Patton N; Filshie R; Nicol A; Ho SJ; Hertzberg M; Mills T; Prosser I; Link E; Cowan L; Zannino D; Seymour JF
    Leuk Lymphoma; 2017 Feb; 58(2):298-307. PubMed ID: 27268068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel fusion of TPR and ALK in lung adenocarcinoma.
    Choi YL; Lira ME; Hong M; Kim RN; Choi SJ; Song JY; Pandy K; Mann DL; Stahl JA; Peckham HE; Zheng Z; Han J; Mao M; Kim J
    J Thorac Oncol; 2014 Apr; 9(4):563-6. PubMed ID: 24736082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype].
    Kim M; Lee JW; Lee JK; Hong YJ; Hong SI; Kang HJ; Cho EH; Chang YH
    Korean J Lab Med; 2010 Aug; 30(4):329-33. PubMed ID: 20805702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821.
    Chang M; Raimondi SC; Ravindranath Y; Carroll AJ; Camitta B; Gresik MV; Steuber CP; Weinstein H
    Leukemia; 2000 Jul; 14(7):1201-7. PubMed ID: 10914543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Nuessler V; Schmetzer H
    Eur J Haematol; 2003 Nov; 71(5):366-76. PubMed ID: 14667200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia.
    Maurillo L; Buccisano F; Spagnoli A; Voso MT; Fianchi L; Papayannidis C; Gaidano GL; Breccia M; Musto P; De Bellis E; Del Principe MI; Lunghi M; Lessi F; Martinelli G; Venditti A
    Ann Hematol; 2018 Oct; 97(10):1767-1774. PubMed ID: 29947973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia.
    Dierlamm J; Stul M; Vranckx H; Michaux L; Weghuis DE; Speleman F; Selleslag D; Kramer MH; Noens LA; Cassiman JJ; Van den Berghe H; Hagemeijer A
    Genes Chromosomes Cancer; 1998 Jun; 22(2):87-94. PubMed ID: 9598794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting.
    Niscola P; Tendas A; Cupelli L; Giovannini M; Piccioni D; Scaramucci L; Dentamaro T; Del Poeta G; de Fabritiis P
    Acta Haematol; 2015; 133(1):64-6. PubMed ID: 25139255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.